260 related articles for article (PubMed ID: 29288943)
21. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation.
Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y
ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and quantitative structure-activity relationships study for phenylpropenamide derivatives as inhibitors of hepatitis B virus replication.
Yang J; Ma M; Wang XD; Jiang XJ; Zhang YY; Yang WQ; Li ZC; Wang XH; Yang B; Ma ML
Eur J Med Chem; 2015 Jun; 99():82-91. PubMed ID: 26057705
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed region.
Yu J; Jia H; Guo X; Desta S; Zhang S; Zhang J; Ding X; Liang X; Liu X; Zhan P
Chem Biol Drug Des; 2020 Jun; 95(6):567-583. PubMed ID: 30825248
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, structure-activity relationships and biological evaluation of dehydroandrographolide and andrographolide derivatives as novel anti-hepatitis B virus agents.
Chen H; Ma YB; Huang XY; Geng CA; Zhao Y; Wang LJ; Guo RH; Liang WJ; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2014 May; 24(10):2353-9. PubMed ID: 24731274
[TBL] [Abstract][Full Text] [Related]
26. Phenylpropenamide derivatives: anti-hepatitis B virus activity of the Z isomer, SAR and the search for novel analogs.
Wang P; Naduthambi D; Mosley RT; Niu C; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2011 Aug; 21(15):4642-7. PubMed ID: 21704526
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and anti-hepatitis B virus activity of C4 amide-substituted isosteviol derivatives.
Huang TJ; Yang CL; Kuo YC; Chang YC; Yang LM; Chou BH; Lin SJ
Bioorg Med Chem; 2015 Feb; 23(4):720-8. PubMed ID: 25600408
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biological evaluation of novel 2'-deoxy-2'-fluoro-2'-C-methyl 8-azanebularine derivatives as potent anti-HBV agents.
Yang W; Peng Y; Wang J; Song C; Yu W; Zhou Y; Jiang J; Wang Q; Wu J; Chang J
Bioorg Med Chem Lett; 2019 Jun; 29(11):1291-1297. PubMed ID: 30962085
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
30. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents.
Guo RH; Zhang Q; Ma YB; Huang XY; Luo J; Wang LJ; Geng CA; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Bioorg Med Chem; 2011 Feb; 19(4):1400-8. PubMed ID: 21292495
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel quinazolinone derivatives as potential anti-HBV and anti-HCC agents.
Qiu J; Zhou Q; Zhang Y; Guan M; Li X; Zou Y; Huang X; Zhao Y; Chen W; Gu X
Eur J Med Chem; 2020 Nov; 205():112581. PubMed ID: 32791397
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect.
Qiu J; Zhou Q; Zou Y; Li S; Yang L; Chen W; Gao J; Gu X
Eur J Med Chem; 2022 Mar; 231():114159. PubMed ID: 35123297
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Bioactivity of
Cui AL; Sun WF; Zhong ZJ; Jin J; Xue ST; Wu S; Li YH; Li ZR
Drug Des Devel Ther; 2020; 14():3723-3729. PubMed ID: 32982177
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs.
Cho JH; Bondana L; Detorio MA; Montero C; Bassit LC; Amblard F; Coats SJ; Schinazi RF
Bioorg Med Chem; 2014 Dec; 22(23):6665-6671. PubMed ID: 25458500
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors.
Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H
Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828
[TBL] [Abstract][Full Text] [Related]
38. Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4).
Ren Q; Liu X; Luo Z; Li J; Wang C; Goldmann S; Zhang J; Zhang Y
Bioorg Med Chem; 2017 Feb; 25(3):1042-1056. PubMed ID: 28082068
[TBL] [Abstract][Full Text] [Related]
39. [Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].
Wu JM; Lin JS; Xie N; Qiu GF; Hu XM
Yao Xue Xue Bao; 2005 Sep; 40(9):825-9. PubMed ID: 16342685
[TBL] [Abstract][Full Text] [Related]
40. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
